General Information of DTT (ID: TTIGYVZ)

DTT Name HUMAN eukaryotic initiation factor-4A (eIF4A) DTT Info
Gene Name EIF4A1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
eFT226 DMHRCQI Solid tumour/cancer 2A00-2F9Z Phase 1/2 [1]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hippuristanol DM0PV2Y T-cell leukaemia 2A90 Investigative [2]
------------------------------------------------------------------------------------
1 Investigative Agents Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Silvestrol DM5JKNF Middle East Respiratory Syndrome (MERS) 1D64 Investigative [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase. J Med Chem. 2020 Jun 11;63(11):5879-5955.
2 Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia. Biochem Pharmacol. 2011 Mar 15;81(6):713-22.
3 Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses. Antiviral Res. 2018 Feb;150:123-129.